State Street’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,606
| Closed | -$27.5K | – | 4764 |
|
|
2023
Q1 | $27.5K | Hold |
7,606
| – | – | ﹤0.01% | 4634 |
|
|
2022
Q4 | $245K | Buy |
7,606
+1,913
| +34% | +$61.6K | ﹤0.01% | 4028 |
|
|
2022
Q3 | $238K | Buy |
5,693
+985
| +21% | +$41.2K | ﹤0.01% | 4069 |
|
|
2022
Q2 | $199K | Sell |
4,708
-24,235
| -84% | -$1.02M | ﹤0.01% | 4200 |
|
|
2022
Q1 | $1.96M | Buy |
28,943
+923
| +3% | +$62.6K | ﹤0.01% | 3574 |
|
|
2021
Q4 | $3.4M | Buy |
28,020
+1,103
| +4% | +$134K | ﹤0.01% | 3427 |
|
|
2021
Q3 | $3.79M | Buy |
26,917
+2,428
| +10% | +$342K | ﹤0.01% | 3377 |
|
|
2021
Q2 | $6.73M | Buy |
24,489
+8,413
| +52% | +$2.31M | ﹤0.01% | 3108 |
|
|
2021
Q1 | $3.44M | Buy |
16,076
+1,358
| +9% | +$291K | ﹤0.01% | 3206 |
|
|
2020
Q4 | $3.56M | Buy |
14,718
+1,628
| +12% | +$394K | ﹤0.01% | 3127 |
|
|
2020
Q3 | $1.38M | Buy |
13,090
+1,560
| +14% | +$164K | ﹤0.01% | 3341 |
|
|
2020
Q2 | $1.13M | Buy |
11,530
+31
| +0.3% | +$3.04K | ﹤0.01% | 3387 |
|
|
2020
Q1 | $864K | Buy |
11,499
+50
| +0.4% | +$3.76K | ﹤0.01% | 3338 |
|
|
2019
Q4 | $930K | Buy |
11,449
+376
| +3% | +$30.5K | ﹤0.01% | 3421 |
|
|
2019
Q3 | $1.35M | Buy |
11,073
+13
| +0.1% | +$1.59K | ﹤0.01% | 3339 |
|
|
2019
Q2 | $1.99M | Buy |
11,060
+816
| +8% | +$147K | ﹤0.01% | 3244 |
|
|
2019
Q1 | $1.64M | Buy |
10,244
+1,890
| +23% | +$302K | ﹤0.01% | 3222 |
|
|
2018
Q4 | $2.17M | Buy |
8,354
+3,550
| +74% | +$924K | ﹤0.01% | 3086 |
|
|
2018
Q3 | $1.17M | Buy |
4,804
+2,664
| +124% | +$649K | ﹤0.01% | 3380 |
|
|
2018
Q2 | $505K | Buy |
+2,140
| New | +$505K | ﹤0.01% | 3466 |
|